The Future of Stem Cell Transplantation: Insights from Dr. Kevin McNerney
In an era where medical science is rapidly transforming lives, stem cell transplantation stands at the forefront of innovative treatment. At the Bone Marrow Transplant and Gene Therapy Congress in Abu Dhabi, Dr. Kevin McNerney from the Ann & Robert H. Lurie Children’s Hospital in Chicago shares groundbreaking updates and real-world insights into this life-saving […]
Stem Cell Therapy for Lymphoma Treatment
Discover how stem cell therapy as a treatment for lymphoma can offer hope and advanced healing options for patients. Explore the transformative approach.
Celularity Revolutionizing Cancer Treatment: The Breakthrough of Stem Cell Therapy
A New Era in Oncology In an exciting development for the field of oncology, Celularity Inc., a leading biotechnology company, is set to present compelling in vivo data at the AACR Annual Meeting 2024. This data showcases the significant impact of their groundbreaking stem cell therapy, PT-CD16, in reducing cancer tumors. Derived from human placental […]
$32.3M Boost: City of Hope’s Groundbreaking Therapies
City of Hope, a prominent cancer research and treatment organization in the United States, has received a grant of $32.3 million from the California Institute for Regenerative Medicine (CIRM). Funding Allocation The funds will be used to support three novel Phase 1 clinical trials that focus on innovative cell and gene therapy treatments for patients […]
Revolution in Cancer Treatment: LIfT’s iPSCs Breakthrough
LIfT BioSciences, a rapidly emerging biotech company, has announced a significant breakthrough in cancer cell therapies. The company has successfully demonstrated proof-of-concept production of its patented cancer-killing alpha neutrophils from induced pluripotent stem cells (iPSCs). This development marks a new era of affordable and effective cancer cell therapies. The company’s second-generation platform, iN-LIfT, derived from […]
Revolution in Oncology: How Stem Cell Transplants are Changing the Game in Cancer Treatment
Welcome, dear reader! It’s a pleasure to have you here as we embark on an enlightening journey into the world of stem cell transplants in oncology. This article is designed for those who are keen to learn more about cancer treatment options or are simply intrigued by the latest advancements in medical science. Consider this […]
Father’s Gift of Life: Young Cancer Warrior Levi Triumphs with Dad’s Stem Cell Help
7-year-old Levi Galvez celebrated being cancer-free at Riley Hospital in Indianapolis on March 27, after a five-year battle with leukemia that began when he was two years old. His father, Geovani Galvez, provided a life-saving stem cell transplant a year ago. The family celebrated the milestone with cheers, laughter, and a small ceremony. Geovani, who […]
One Niche to Rule Them All: Stem Cell-Lymphatic Interactome in Regeneration and Cancer
Shiri Gur-Cohen, Ph.D., UC San Diego, explains how her lab studies how epithelial stem cells communicate with their vascular microenvironment to advance regeneration and combat metastatic diseases. Video Transcript: [MUSIC] I’m excited to share with you today the work that we’re doing in my laboratory to enhance regeneration and to fight cancer. In my laboratory, […]
Updated Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T cell therapy
HOUSTON, Texas, Dec. 20, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. and CTMC, a joint venture between MD Anderson Cancer Center and National Resilience, Inc., today announced Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for a Phase 1/2a clinical study of IVS-3001, Invectys’s lead engineered human leukocyte antigen A (HLA-G) targeting chimeric antigen […]
IN8bio Announces FDA Clearance to Initiate a Phase 2 Clinical Trial of INB-400 Gamma-Delta T Cells for Glioblastoma
NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase 2 clinical trial of a genetically modified […]